Financials
- Market Capitalization 1.91 B
- Employee 435
- Founded 2005
- CEO N/A
- Website www.xerispharma.com
- Headquarter Illinois, United States
- FIGI BBG012V1MG52
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
—
Rapporto prezzo/fatturato
4.65
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 1961 | MLYS Mineralys Therapeutics, Inc. - Common Stock | 22.23 USD | -4.88% | -5.56% | -21.00% | -44.93% | 1.97 B USD | ||
| 1977 | VIR Vir Biotechnology, Inc. - Common Stock | 11.30 USD | -3.42% | -5.04% | +5.31% | +88.96% | 1.91 B USD | ||
| 1990 | URGN UroGen Pharma Ltd. - Ordinary Shares | 38.28 USD | +3.94% | -11.47% | -9.63% | +101.47% | 1.87 B USD | ||
| 1994 | XNCR Xencor, Inc. - Common Stock | 25.04 USD | +1.66% | -2.80% | +1.34% | +79.50% | 1.86 B USD |